Journal
CARDIOVASCULAR RESEARCH
Volume 77, Issue 2, Pages 265-273Publisher
ELSEVIER SCIENCE BV
DOI: 10.1093/cvr/cvm056
Keywords
atria; ventricle; SR Ca2+ ATPase; phospholamban; sarcolipin; calcium; cardiac contractility
Categories
Funding
- NHLBI NIH HHS [HL-64140] Funding Source: Medline
Ask authors/readers for more resources
Cardiac sarcoplasmic reticulum (SR) Ca2+ ATPase (SERCA2a) plays a central role in myocardial contractility. SERCA2a actively transports Ca2+ into the SR and regulates cytosolic Ca2+ concentration, SR Ca2+ toad, and the rate of contraction and relaxation of the heart. In the heart, SERCA pump activity is regulated by two small molecular weight proteins: phospholamban (PLB) and sarcolipin (SLN). Decreases in the expression levels of SERCA2a have been observed in a variety of pathological conditions. In addition, altered expression of PLB and SLN has been reported in many cardiac diseases. Thus, SERCA2a is a major regulator of intracellular Ca2+ homeostasis, and changes in the expression and activity of the SERCA pump contribute to the decreased SR Ca2+ content and cardiac dysfunction during pathogenesis. In this review, we discuss the mechanisms controlling SERCA pump expression and activity both during normal physiology and under pathological states.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available